Inward Investor: Teva is ready to reap a generic windfall

Teva Pharmaceutical Industries, which has a significant presence in Ireland, is well positioned to benefit from the increased demand for generic drugs.

25th November, 2012
Inward Investor: Teva is ready to reap a generic windfall
Teva is set to benefit from drug patent protection. Photo: Bloomberg

The multibillion dollar generic drug industry is both a cut-throat and highly lucrative one in which small 'David' drug makers are snapped up by Goliath pharma companies constantly on the look-out for the next big thing in order to ensure their survival.

The expiry of patent protection on several heavyweight drugs over the next three years is expected to herald a golden era of productivity and prosperity for generic drug manufacturers.

The pharmaceutical companies most...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago